Be the first to like this
Paul Kohlhaas, CEO of the blockchain company Linumlabs, presented the software platform Molecule. It creates a crypto marketplace unlocking open source mechanisms in drug development, enabling the distribution of cost, risk and ownership. Too ambitious a vision? Check out the alpha version promised for Q3 2019!